Pfizer Newswire

Pfizer Newswire

Comprehensive Real-Time News Feed for Pfizer.

Results 1 - 20 of 4,333 in Pfizer

  1. Anti-Thrombin Activators Market: Upcoming Demands and Growth Analysis 2024Read the original story w/Photo

    1 hr ago | SBWire

    ... in the global anti-thrombin market are Boehringer Ingelheim, Astra Zeneca, Bristol-Myers Squibb, Novartis AG, Pfizer, GlaxoSmithKline Plc., Bayer International, Eli Lilly & Co., and Johnson & Johnson. Contact us: Transparency Market Research 90 ...

    Comment?

  2. Pfizer, Inc. (PFE) PT Set at $43.00 by Cowen and CompanyRead the original story w/Photo

    6 hrs ago | IntersportsWire

    ... A number of other brokerages have also recently issued reports on PFE. Barclays PLC set a $38.00 price objective on Pfizer and gave the stock a "buy" rating in a report on Thursday, March 16th. Jefferies Group LLC reiterated a "neutral" rating and ...

    Comment?

  3. Merck & Co. And Pfizer Collaborate With Corning To Modernize Pharmaceutical Glass PackagingRead the original story

    Thursday | BioSpace

    Collaborations result in development of Corning Valor Glass; drive significant U.S. investment and job creation The White House Office of American Innovation facilitates cross-industry technology collaboration and U.S. investment CORNING, N.Y.; JULY 20, 2017 - Merck , Pfizer and Corning Incorporated today announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor Glass. This revolutionary pharmaceutical glass packaging solution enhances the storage and delivery of today's drug formulations and provides more reliable access to medicines essential to public health.

    Comment?

  4. Trump: Corning considering major investment in the SoutheastRead the original story

    11 hrs ago | Business Journal

    ... At a White House event Thursday, Trump said Corning Inc. is investing $500 million alongside pharma firms Merck and Pfizer to manufacture a new, more resilient kind of glass for injectable drug vials. The move means nearly 1,000 jobs at ...

    Comment?

  5. EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell CarcinomaRead the original story

    12 hrs ago | Newkerala.com

    DARMSTADT, Germany and NEW YORK, July 20, 2017 : Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of avelumab* as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma , a rare and aggressive skin cancer. The European Commission will now review the CHMP's recommendation, with a decision expected in the third quarter of 2017.

    Comment?

  6. Trump brings companies to White House for another jobs announcementRead the original story w/Photo

    12 hrs ago | WEHT

    On Thursday, he unveiled an agreement between pharmaceutical giants Pfizer and Merck and New York-based manufacturer Corning to produce a new type of glass for storing and delivering injectable drugs. Corning will initially invest $500 million in the project, a move that will create 1,000 new U.S. jobs.

    Comment?

  7. Northpointe Capital LLC Has $4.76 Million Position in Pfizer, Inc.Read the original story w/Photo

    13 hrs ago | IntersportsWire

    Northpointe Capital LLC boosted its position in shares of Pfizer, Inc. by 0.0% during the first quarter, Holdings Channel reports. The fund owned 139,170 shares of the biopharmaceutical company's stock after buying an additional 49 shares during the period.

    Comment?

  8. CAPROCK Group Inc. Lowers Stake in Pfizer, Inc.Read the original story w/Photo

    15 hrs ago | IntersportsWire

    CAPROCK Group Inc. cut its position in shares of Pfizer, Inc. by 6.4% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 91,034 shares of the biopharmaceutical company's stock after selling 6,236 shares during the period.

    Comment?

  9. Pfizer Target of Unusually Large Options TradingRead the original story w/Photo

    15 hrs ago | Daily Political

    Pfizer, Inc. was the recipient of some unusual options trading on Tuesday. Traders purchased 21,983 put options on the stock.

    Comment?

  10. Merck KGaA Release: EMA's Issues Positive Opinion For Avelumab For...Read the original story

    Thursday | BioSpace

    Merck KGaA Release: EMA 's CHMP Issues Positive Opinion For Avelumab For The Treatment Of Metastatic Merkel Cell Carcinoma , and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of avelumab* as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma , a rare and aggressive skin cancer. The European Commission will now review the CHMP's recommendation, with a decision expected in the third quarter of 2017.

    Comment?

  11. Aceto Subsidiary, Rising Pharma, Announces Product LaunchesRead the original story

    Thursday | BioSpace

    PORT WASHINGTON, N.Y., July 21, 2017 -- ACETO Corporation , an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, recently launched: Ramipril Capsules, 1.25mg, 2.5mg, 5mg, and 10mg, an FDA-approved generic version of the reference listed drug, AltaceA from Pfizer, which is indicated for the treatment of hypertension. Losartan Potassium Tablets, 25mg and 50mg, an FDA-approved generic version of the reference listed drug, CozaarA from Merck, which is also indicated for the treatment of hypertension.

    Comment?

  12. Trump touts jobs from new medicine vial agreementRead the original story w/Photo

    Thursday | NorthJersey.com

    ... CEO of Corning Glass, gets ready to try to crush a Valor Glass protective vial during an event to announce a Merck, Pfizer, and Corning joint partnership at the White House on Thursday. Corning Inc. will add 1,000 jobs at plant in Vineland and near ...

    Comment?

  13. Pfizer, Inc. (NYSE:PFE) Shares Bought by Bollard Group LLCRead the original story w/Photo

    22 hrs ago | IntersportsWire

    Bollard Group LLC raised its position in shares of Pfizer, Inc. by 5.6% during the first quarter, according to its most recent filing with the SEC. The fund owned 74,315 shares of the biopharmaceutical company's stock after buying an additional 3,964 shares during the period.

    Comment?

  14. Trump's finances expected to face Mueller's scrutiny despite president's warningRead the original story w/Photo

    Yesterday | The Japan Times

    U.S .President Donald Trump looks on during the announcement of a a newly designed, Made in America pharmaceutical glass bottle jointly developed by Merck, Pfizer and Corning during a Made in America Week event in the Roosevelt Room of the White House in Washington Thursday. President Donald Trump's growing anxiety about the federal Russia probe has spilled into public view with his warning that special counsel Robert Mueller would be out of bounds if he dug into the Trump family's finances.

    Comment?

  15. Pfizer, Inc. (PFE) Stock Rating Lowered by Credit Suisse GroupRead the original story w/Photo

    Yesterday | AmericanBankingNews.com

    ... also weighed in on PFE. Sanford C. Bernstein reiterated a "buy" rating and set a $35.00 price objective on shares of Pfizer in a research note on Friday, March 24th. Barclays PLC reiterated a "buy" rating and set a $38.00 price objective on shares ...

    Comment?

  16. Pfizer, Merck, Corning Inc. team up on pharmaceutical glassRead the original story w/Photo

    Thursday | WENY

    On Thursday, he unveiled an agreement between pharmaceutical giants Pfizer and Merck and New York-based manufacturer Corning to produce a new type of glass for storing and delivering injectable drugs. Corning will initially invest $500 million in the project, a move that will create 1,000 new U.S. jobs.

    Comment?

  17. Pfizer Inc. (PFE) Stake Increased by Excalibur Management CorpRead the original story w/Photo

    Thursday | IntersportsWire

    Excalibur Management Corp boosted its position in Pfizer Inc. by 1.3% during the first quarter, Holdings Channel reports. The firm owned 181,542 shares of the biopharmaceutical company's stock after buying an additional 2,329 shares during the period.

    Comment?

  18. New York Times a favorite Trump target - and interview venueRead the original story w/Photo

    Thursday | Albany Times Union

    President Donald Trump speaks during an event to announce a Merck, Pfizer, and Corning joint partnership to make glass containers for medication, in the Roosevelt Room of the White House, Thursday, July 20, 2017, in Washington. With Trump are Rep. Tom Reed, R-N.Y., left, and Health and Human Services Secretary Tom Price.

    Comment?

  19. Pfizer, Inc. (NYSE:PFE) Position Lowered by Gateway Investment Advisers LLCRead the original story w/Photo

    Thursday | IntersportsWire

    Gateway Investment Advisers LLC reduced its position in shares of Pfizer, Inc. by 2.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 3,241,569 shares of the biopharmaceutical company's stock after selling 72,702 shares during the period.

    Comment?

  20. Trump unveils companies' US$500 million US drug packaging projectRead the original story w/Photo

    Thursday | Channelnewsasia.com

    Corning Inc said at an event with U.S. President Donald Trump on Thursday that it plans to spend US$500 million and create 1,000 jobs in the United States making a new kind of glass for vials and cartridges to hold injectable drugs. U.S. President Trump participates in a strength vial test accompanied by Corning Pharmaceutical Glass Chairman and CEO Weeks during a "Made in America" event in Washington WASHINGTON: President Donald Trump on Thursday announced a US$500 million investment that Corning Inc is making with pharmaceutical giants Merck and Pfizer to manufacture a new kind of glass for injectable drug vials.

    Comment?